ORLANDI, ENRICO
ORLANDI, ENRICO
A long-term time course of colorimetric assessment of the effects of imatinib mesylate on skin pigmentation: a study of five patients
2007-01-01 Brazzelli, V; Prestinari, F; Barbagallo, T; Rona, Claudia; Orlandi, E; Passamonti, F; Locatelli, F; Zecca, M; Villani, S; Borroni, G.
Gynecological radio-induced secondary malignancy after a gynecological primary tumor: a rare entity and a challenge for oncologists
2022-01-01 Barcellini, A.; Dominoni, M.; Gardella, B.; Mangili, G.; Orlandi, E.
Hand in hand: A multistakeholder approach for co-production of surgical care
2022-01-01 Cobianchi, L.; Dal Mas, F.; Massaro, M.; Bednarova, R.; Biancuzzi, H.; Filisetti, C.; Barcellini, A.; Orlandi, E.; Miceli, L.; Angelos, P.
Immunonutrition in head and neck cancer patients undergoing chemoradiotherapy: An alternative approach for overcoming potential bias
2021-01-01 Caccialanza, R.; Cereda, E.; Orlandi, E.; Filippi, A. R.; Comoli, P.; Alberti, A.; Imarisio, I.; Pedrazzoli, P.; Bossi, P.
Omentum flap as a spacer before carbon ion radiotherapy for gynecological recurrences. A technical note
2022-01-01 Barcellini, A; Mirandola, A; Fiore, M R; Orlandi, E; Cobianchi, L
Please mind the gap-about equity and access to care in oncology
2021-01-01 Barcellini, A; Dal Mas, F; Paoloni, P; Loap, P; Cobianchi, L; Locati, L; Rodríguez-Luna, M R; Orlandi, E
Preoperative Carbon Ion Radiotherapy (CIRT) with Chemotherapy in Resectable and Borderline Resectable Pancreatic Adenocarcinoma (PCa): A Multicenter Prospective Phase II Clinical Study (Pioppo Study NCT 03822936)
2023-01-01 Barcellini, A.; Vitolo, V.; Cobianchi, L.; Vanoli, A.; Butturini, G.; Brugnatelli, S.; Pagani, A.; Fossati, P.; Preda, L.; Peloso, A.; Klersy, C.; Facoetti, A.; Molinelli, S.; Ciocca, M.; Imparato, S.; Pecorilla, M.; Orlandi, E.; Valvo, F.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A long-term time course of colorimetric assessment of the effects of imatinib mesylate on skin pigmentation: a study of five patients | 1-gen-2007 | Brazzelli, V; Prestinari, F; Barbagallo, T; Rona, Claudia; Orlandi, E; Passamonti, F; Locatelli, F; Zecca, M; Villani, S; Borroni, G. | |
| Gynecological radio-induced secondary malignancy after a gynecological primary tumor: a rare entity and a challenge for oncologists | 1-gen-2022 | Barcellini, A.; Dominoni, M.; Gardella, B.; Mangili, G.; Orlandi, E. | |
| Hand in hand: A multistakeholder approach for co-production of surgical care | 1-gen-2022 | Cobianchi, L.; Dal Mas, F.; Massaro, M.; Bednarova, R.; Biancuzzi, H.; Filisetti, C.; Barcellini, A.; Orlandi, E.; Miceli, L.; Angelos, P. | |
| Immunonutrition in head and neck cancer patients undergoing chemoradiotherapy: An alternative approach for overcoming potential bias | 1-gen-2021 | Caccialanza, R.; Cereda, E.; Orlandi, E.; Filippi, A. R.; Comoli, P.; Alberti, A.; Imarisio, I.; Pedrazzoli, P.; Bossi, P. | |
| Omentum flap as a spacer before carbon ion radiotherapy for gynecological recurrences. A technical note | 1-gen-2022 | Barcellini, A; Mirandola, A; Fiore, M R; Orlandi, E; Cobianchi, L | |
| Please mind the gap-about equity and access to care in oncology | 1-gen-2021 | Barcellini, A; Dal Mas, F; Paoloni, P; Loap, P; Cobianchi, L; Locati, L; Rodríguez-Luna, M R; Orlandi, E | |
| Preoperative Carbon Ion Radiotherapy (CIRT) with Chemotherapy in Resectable and Borderline Resectable Pancreatic Adenocarcinoma (PCa): A Multicenter Prospective Phase II Clinical Study (Pioppo Study NCT 03822936) | 1-gen-2023 | Barcellini, A.; Vitolo, V.; Cobianchi, L.; Vanoli, A.; Butturini, G.; Brugnatelli, S.; Pagani, A.; Fossati, P.; Preda, L.; Peloso, A.; Klersy, C.; Facoetti, A.; Molinelli, S.; Ciocca, M.; Imparato, S.; Pecorilla, M.; Orlandi, E.; Valvo, F. |